Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2018
Price : $35 *
At a glance
- Drugs Eplerenone (Primary)
- Indications Hypertension; Insulin resistance
- Focus Pharmacodynamics; Therapeutic Use
- 01 Nov 2018 Status changed from recruiting to discontinued due to failure to recruit sufficient participants
- 05 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Nov 2018.
- 03 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.